Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

被引：0
作者：
Se Hoon Park
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
Woon KI Lee
Min Chung
机构：
[1] Gachon Medical School Gil Medical Center,Division of Hematology and Oncology, Department of Internal Medicine
[2] Gachon Medical School Gil Medical Center,Department of General Surgery
来源：
BMC Cancer | / 5卷
关键词：
Gastric Cancer; Docetaxel; Dose Level; Febrile Neutropenia; Dose Escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase I study of Paclitaxel, Cisplatin and 5-fluorouracil combination chemotherapy for unresectable/recurrent gastric cancer
    Kato, J.
    Nagahara, A.
    Iijima, K.
    Kodani, T.
    Higashihara, Y.
    Yoshimura, M.
    Serizawa, N.
    Osada, T.
    Yoshizawa, T.
    Otaka, M.
    Watanabe, S.
    ADVANCES IN MEDICAL SCIENCES, 2010, 55 (02): : 137 - 142
  • [42] Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
    Shirao, Kuniaki
    Boku, Narikazu
    Yamada, Yasuhide
    Yamaguchi, Kensei
    Doi, Toshihiko
    Goto, Masahiro
    Nasu, Junichiro
    Denda, Tadamichi
    Hamamoto, Yasuo
    Takashima, Atsuo
    Fukuda, Haruhiko
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (10) : 972 - 980
  • [43] A Phase I Trial of Oblimersen Sodium in Combination With Cisplatin and 5-Fluorouracil in Patients With Advanced Esophageal, Gastroesophageal Junction, and Gastric Carcinoma
    Raab, Rachel
    Sparano, Joseph A.
    Ocean, Allyson J.
    Christos, Paul
    Ramirez, Mark
    Vinciguerra, Vincent
    Kaubisch, Andreas
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (01): : 61 - 65
  • [44] Pilot study of combined treatment with continuous infusion of 5-fluorouracil, mitomycin C, and cisplatin (FMP) in patients with inoperable advanced gastric cancer
    Koizumi, W
    Tanabe, S
    Kurihara, M
    Kondou, I
    Yamazaki, I
    Saigenji, K
    ONCOLOGY REPORTS, 1999, 6 (03) : 643 - 646
  • [45] Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study
    Lortholary, A
    Maillard, P
    Delva, R
    Boisdron-Celle, M
    Perard, D
    Vernillet, L
    Besenval, M
    Gamelin, E
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) : 1773 - 1780
  • [46] A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer
    Kim, R
    Murakami, S
    Ohi, Y
    Inoue, H
    Yoshida, K
    Toge, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (05) : 921 - 926
  • [47] A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancer
    Thatai, Lata Chandi
    Vishnubhotla, Priya
    Biernat, Laura
    Flaherty, Lawrence
    LoRusso, Patricia
    Simon, Michael
    Stephens, Deanna
    Vereeke, Kelly
    Abrams, Judith
    Bouwman, David
    Philip, Philip A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05): : 484 - 489
  • [48] Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer
    Tatsuya Miyazaki
    Hitoshi Ojima
    Minoru Fukuchi
    Makoto Sakai
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Kana Saito
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Annals of Surgical Oncology, 2015, 22 : 3653 - 3658
  • [49] A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
    Delord, Jean Pierre
    Dalenc, Florence
    Pinguet, Frederic
    Nguyen, Laurent
    Lochon, Isabelle
    Poublanc, Muriel
    Chatelut, Etienne
    Roche, Henri
    ONCOLOGY, 2007, 72 (5-6) : 322 - 325
  • [50] Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Van Laer, C
    Awada, A
    Van den Weyngaert, D
    Nguyen, H
    Le Bouder, C
    Castelijns, JA
    Kaanders, J
    De Mulder, P
    Vermorken, JB
    ANNALS OF ONCOLOGY, 2004, 15 (04) : 638 - 645
12345